Literature DB >> 21033244

Significance of increased serum GGTP levels in HCC patients.

Brian I Carr1, Petr Pancoska, Robert A Branch.   

Abstract

A large dataset of patients with biopsy-proven and unresectable HCC who were prospectively followed from diagnosis till death, was examined for the prognostic significance of serum GGTP levels. Their survival-ordered baseline clinical parameter data was examined. Two cohorts of patients with both low AFP and bilirubin levels were identified, who had serum GGTP levels with an increasing trend with increasing AFP levels. The survival of these patients also decreased as their GGTP levels trended up, as did their tumor masses. By contrast, in patients with elevated serum AFP levels, the GGTP trends were less informative, although patients with the highest AFP levels had a worse prognosis if their GGTP levels were simultaneously elevated. The results suggest that following trends in serum GGTP levels, in the context of specific ranges of AFP and bilirubin levels, might be useful in diagnosis of small HCCs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21033244

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  13 in total

1.  Validation of a Liver Index and Its Significance for HCC Aggressiveness.

Authors:  Brian I Carr; Vito Guerra
Journal:  J Gastrointest Cancer       Date:  2017-09

2.  Small HCCs identified by screening.

Authors:  Petr Pancoska; Massimo De Giorgio; Stefano Fagiuoli; Brian I Carr
Journal:  Dig Dis Sci       Date:  2011-04-05       Impact factor: 3.199

3.  HCC with low- and normal-serum alpha-fetoprotein levels.

Authors:  Brian I Carr; Hikmet Akkiz; Oguz Üsküdar; Kendal Yalçın; Vito Guerra; Sedef Kuran; Ümit Karaoğullarından; Engin Altıntaş; Ayşegül Özakyol; Salih Tokmak; Tuğsan Ballı; Mehmet Yücesoy; Halil İbrahim Bahçeci; Abdulalh Ülkü; Tolga Akçam; Kamil Yalçın Polat; Nazım Ekinci; Halis Şimşek; Necati Örmeci; Abdulalh Sonsuz; Mehmet Demir; Murat Kılıç; Ahmet Uygun; Ali Demir; Anıl Delik; Burcu Arslan; Figen Doran; Sezai Yilmaz; Yaman Tokat
Journal:  Clin Pract (Lond)       Date:  2018

4.  Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.

Authors:  Yi-Peng Fu; Yong Yi; Jin-Long Huang; Chu-Yu Jing; Jian Sun; Xiao-Chun Ni; Zhu-Feng Lu; Ya Cao; Jian Zhou; Jia Fan; Shuang-Jian Qiu
Journal:  Oncologist       Date:  2017-04-24

5.  An efficient model for auxiliary diagnosis of hepatocellular carcinoma based on gene expression programming.

Authors:  Li Zhang; Jiasheng Chen; Chunming Gao; Chuanmiao Liu; Kuihua Xu
Journal:  Med Biol Eng Comput       Date:  2018-03-16       Impact factor: 2.602

6.  Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.

Authors:  Brian I Carr; Vito Guerra
Journal:  Oncology       Date:  2013-08-29       Impact factor: 2.935

7.  Change in γ-glutamyl transpeptidase activity as a useful tool in identifying a group of patients with elevated risk of hepatocellular carcinoma development after DAA treatment of chronic hepatitis C.

Authors:  Dorota Orzechowska; Katarzyna Klimowicz; Anna Stępień; Tomasz Mikuła; Mariusz Sapuła; Alicja Wiercińska-Drapało
Journal:  Clin Exp Hepatol       Date:  2021-03-15

Review 8.  Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring.

Authors:  Li Wang; Min Yao; Zhizhen Dong; Yun Zhang; Dengfu Yao
Journal:  Tumour Biol       Date:  2013-09-05

9.  Preoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection.

Authors:  Wan-Li Wang; Xing-Long Zheng; Zhi-Yong Zhang; Ying Zhou; Jie Hao; Gang Tang; Ou Li; Jun-Xi Xiang; Zheng Wu; Bo Wang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

10.  Chemotherapeutic potential of curcumin-bearing microcells against hepatocellular carcinoma in model animals.

Authors:  Mohammad Farazuddin; Bhavyata Dua; Qamar Zia; Aijaz Ahmad Khan; Beenu Joshi; Mohammad Owais
Journal:  Int J Nanomedicine       Date:  2014-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.